Drug Pipeline

Dual-target CAR-NK cells Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
7
Active Studies
7
Recruiting
1
Top Sponsors
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-06-11 NCT07641023 Dual-Target CAR-NK Cells Targeting MSLN, EGFR, or HER2 in Advanced NSCLC Phase 1/2 Recruiting
Active Studies by Phase
Phase 1/2
5
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT07467863 Dual-Target CAR-NK Cells Directed Against MSLN, EGFR, or HER2 in Advanced NSCLC Non-Small Cell Lung Cancer Recruiting
NCT07486089 Dual-Target CAR-NK Cells for Advanced Breast Cancer (HER2+ and TNBC) Breast Cancer (Locally Advanced or Metastatic) Recruiting
NCT07510802 Dual-Target CAR-NK Cells for Advanced Breast Cancer HER2+ TNBC Breast Cancer (Advanced/Metastatic) Recruiting
NCT07551362 Dual-target CLDN18.2/HER2 CAR-NK Cells for Advanced Gastric/GEJ Cancer Advanced Gastric Adenocarcinoma Recruiting
NCT07641023 Dual-Target CAR-NK Cells Targeting MSLN, EGFR, or HER2 in Advanced NSCLC Non-Small Cell Lung Cancer Recruiting
Phase 1
NCT07480941 Dual-Targeting CAR-NK Cells for Recurrent/Progressive Glioblastoma and High-Grade Glioma Glioblastoma Recruiting
NCT07551336 Dual-Targeting CAR-NK Cells for Recurrent/Progressive Glioblastoma and High-Grade Glioma Malignant Glioma Recruiting
Sponsors Running Dual-target CAR-NK cells Trials
Beijing Biotech (7)
Disease Areas
Non-Small Cell Lung Cancer (NSCLC) (2) Lung Cancer (2) Glioblastoma (2) Glioma (2) Breast Cancer (2) Triple-Negative Breast Cancer (2) HER2-Positive Breast Cancer (2)
Get alerts when Dual-target CAR-NK cells trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free